Newly confirmed Air Force Secretary Dr. Troy Meink told Air Force Academy graduates Thursday they were being commissioned as ...

Add three more University of Virginia faculty members to the list of American Academy of Arts & Sciences fellows. The prestigious honorary society and research center announced April 23 that biology ...

Congratulations to graduates of the Air Force Academy’s Class of 2025. Each will cross the stage Thursday before taking on careers that protect freedom and American sovereignty.

Professor Graham Coop, Department of Evolution and Ecology and Director of the Center for Population Biology, has been elected as a Fellow of the American Academy of Arts and Sciences for his work on ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Corvus Pharmaceuticals Inc. (CRVS) on Thursday reported net income of $15 million in its first quarter. On a per-share ...

Investing.com -- Shares of Corvus Pharmaceuticals Inc (NASDAQ:CRVS) climbed 18.2% following the release of encouraging interim data from their Phase 1 clinical trial of soquelitinib in patients ...

Princeton faculty members William Bialek, Kai Li, Peter Singer and Christopher Skinner have been elected to the American Academy of Arts and Sciences for distinguished work in their disciplines. They ...

71.1% EASI reduction in high-dose group vs. 42.1% for placebo after 28 days. No dose-limiting toxicities or major lab abnormalities observed in any cohort. Unlock your all-in-one trading dashboard ...

CEO Miller acknowledged, “We have to put that in a little bit of perspective.” Corvus Pharmaceuticals’ Q1 2025 results highlighted significant progress in developing soquelitinib ...

Corvus Pharmaceuticals Inc (NASDAQ:CRVS) reported a net income of $15.2 million for Q1 2025, a significant improvement from a net loss of $5.7 million in Q1 2024. The company recorded a non-cash ...

When people turn their radio to 97.7 in the Colorado Springs area, they're listening to a cadet-run radio station. News5 had ...

On Tuesday, Mizuho Securities adjusted its price target for Corvus Pharmaceuticals (NASDAQ: CRVS) stock, reducing it from $12.00 to $11.00 while maintaining an Outperform rating.Currently trading ...